Detalhe da pesquisa
1.
A randomized controlled trial of long-acting muscarinic antagonist and long-acting ß2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease.
BMC Pulm Med
; 21(1): 26, 2021 Jan 13.
Artigo
Inglês
| MEDLINE | ID: mdl-33441146